Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by Aβ aggregation in SH-SY5Y cells

Neuroscience Letters

Volumn 492, Issue 2, 2011, Pages 76-79

  Yin, Fei ^a,b   Liu, Jianhui ^a,b   Ji, Xiuhong ^b   Wang, Yanwen ^b   Zidichouski, Jeffrey ^b   Zhang, Junzeng ^b  

^a CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

A ; Aggregation; Baicalin; Copper; Hydrogen peroxide

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BAICALIN; HYDROGEN PEROXIDE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CELL AGGREGATION; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; CELL LINE, TUMOR; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLAVANONES; HUMANS; HYDROGEN PEROXIDE; NEUROBLASTOMA; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHENOL; PLANT EXTRACTS; SCUTELLARIA BAICALENSIS; TIME FACTORS;

EID: 79952070249     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.055     Document Type: Article

References (33)

1. Adlard P.A., Bush A.I. Metals and Alzheimer's disease. J. Alzheimers Dis. 2006, 10:145-163.
2. Aguzzi A., O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat. Rev. Drug Discov. 2010, 9:237-248.
3. Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhara Y., Wakui Y., Sakashita Y., Kobashi K. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 2000, 52:1563-1568.
4. Behl C, Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
5. Bush A.I. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol. Aging 2002, 23:1031-1038.
6. Bush A.I., Tanzi R.E. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 2008, 5:421-432.
7. Cao Y., Li G., Wang Y.F., Fan Z.K., Yu D.S., Wang Z.D., Bi Y.L. Neuroprotective effect of baicalin on compression spinal cord injury in rats. Brain Res. 2010, 1357:115-123.
8. Cuajungco M.P., Frederickson C.J., Bush A.I. Amyloid-beta metal interaction and metal chelation. Subcell Biochem. 2005, 38:235-254.
9. Dikalov S.I., Vitek M.P., Mason R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radic. Biol. Med. 2004, 36:340-347.
10. Gao Z., Huang K., Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol. Res. 2001, 43:173-178.
11. Ge Q.F., Hu X., Ma Z.Q., Liu J.R., Zhang W.P., Chen Z., Wei E.Q. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons. Pharmacol. Res. 2007, 55:148-157.
12. Heo H.J., Kim D.O., Choi S.J., Shin D.H., Lee C.Y. Potent Inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J. Agric. Food Chem. 2004, 52:4128-4132.
13. Hou Y.C., Lin S.P., Tsai S.Y., Ko M.H., Chang Y.C., Chao P.D. Flavonoid pharmacokinetics and tissue distribution after repeated dosing of the roots of Scutellaria baicalensis in rats. Planta Med. 2010, 10.1055/s-0030-1250433.
14. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999, 38:7609-7616.
15. Hung Y.H., Bush A.I., Cherny R.A. Copper in the brain and Alzheimer's disease. J. Biol. Inorg. Chem. 2010, 15:61-76.
16. Ikezoe T., Chen S.S., Heber D., Taguchi H., Koeffler H.P. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Prostate 2001, 49:285-292.
17. Janusz M., Woszczyna M., Lisowski M., Kubis A., Macala J., Gotszalk T., Lisowski J. Ovine colostrum nanopeptide affects amyloid beta aggregation. FEBS Lett. 2009, 583:190-196.
18. Lai M.Y., Hsiu S.L., Tsai S.Y., Hou Y.C., Chao P.D. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J. Pharm. Pharmacol. 2003, 55:205-209.
19. Li C.T., Zhang W.P., Fang S.H., Lu Y.B., Zhang L.H., Qi L.L., Huang X.Q., Huang X.J., Wei E.Q. Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells. Acta Pharmacol. Sin. 2010, 31:137-144.
20. Liao L., Cheng D., Wang J., Duong D.M., Losik T.G., Gearing M., Rees H.D., Lah J.J., Levey A.I., Peng J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 2004, 279:37061-37068.
21. Liu L.Y., Wei E.Q., Zhao Y.M., Chen F.X., Wang M.L., Zhang W.P., Chen Z. Protective effects of baicalin on oxygen/glucose deprivation- and NMDA-induced injuries in rat hippocampal slices. J. Pharm. Pharmacol. 2005, 57:1019-1026.
22. Lleo A., Greenberg S.M., Growdon J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 2006, 57:513-533.
23. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
24. Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
25. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Beher D., Masters C.L., Beyreuther K. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol. 1997, 54:533-539.
26. Opazo C., Huang X., Cherny R.A., Moir R.D., Roher A.E., White A.R., Cappai R., Masters C.L., Tanzi R.E., Inestrosa N.C., Bush A.I. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J. Biol. Chem. 2002, 277:40302-40308.
27. Rogers J.T., Bush A.I., Cho H.H., Smith D.H., Thomson A.M., Friedlich A.L., Lahiri D.K., Leedman P.J., Huang X., Cahill C.M. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem. Soc. Trans. 2008, 36:1282-1287.
28. Shen Y.C., Chiou W.F., Chou Y.C., Chen C.F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur. J. Pharmacol. 2003, 465:171-181.
29. Tabner B.J., El-Agnaf O.M., Turnbull S., German M.J., Paleologou K.E., Hayashi Y., Cooper L.J., Fullwood N.J., Allsop D. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J. Biol. Chem. 2005, 280:35789-35792.
30. Tarrago T., Kichik N., Claasen B., Prades R., Teixido M., Giralt E. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorg. Med. Chem. 2008, 16:7516-7524.
31. Tu X.K, Yang W.Z., Shi S.S., Wang C.H., Chen C.M. Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochem. Res. 2009, 34:1626-1634.
32. Xu G., Dou J., Zhang L., Guo Q., Zhou C. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol. Pharm. Bull. 2010, 33:238-243.
33. Zhang L., Xing D., Wang W., Wang R., Du L. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract. J. Ethnopharmacol. 2006, 103:120-125.